The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat

Brain Research

Volumn 1127, Issue 1, 2007, Pages 90-98

  Boules, Mona ^a   Iversen, Iver ^b   Oliveros, Alfredo ^a   Shaw, Amanda ^a   Williams, Katrina ^a   Robinson, Jessica ^a   Fredrickson, Paul ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NORTH FLORIDA   (United States)

Author keywords

Dopamine; Extinction; Glucocorticoid; Neurotensin; Reinforcement

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; MESSENGER RNA; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR AGONIST; NT 69L; SUCROSE; TYROSINE 3 MONOOXYGENASE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISCRIMINATION LEARNING; DRUG EFFECT; DRUG MECHANISM; INSTRUMENTAL CONDITIONING; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REINFORCEMENT; REWARD;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, OPERANT; DOPAMINE; EXTINCTION, PSYCHOLOGICAL; FOOD DEPRIVATION; MALE; NEUROTENSIN; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, NEUROTENSIN; REINFORCEMENT (PSYCHOLOGY); RNA, MESSENGER; SELF ADMINISTRATION; SUCROSE; TYROSINE 3-MONOOXYGENASE;

EID: 33845211168     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.10.025     Document Type: Article

References (56)

1. Ator N.A. Subjects and Instrumentation (1991), Elsevier, New York
2. Bassareo V., and Di Chiara G. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89 (1999) 637-641
3. Belda X., Ons S., Carrasco J., and Armario A. The effects of chronic food restriction on hypothalamic-pituitary-adrenal activity depend on morning versus evening availability of food. Pharmacol. Biochem. Behav. 81 (2005) 41-46
4. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
5. Boules M., Cusack B., Zhao L., Fauq A., McCormick D.J., and Richelson E. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents. Brain Res. 865 (2000) 35-44
6. Boules M., Warrington L., Fauq A., McCormick D.J., and Richelson E. A novel neurotensin analog blocks cocaine- and d-amphetamine-induced hyperactivity. Eur. J. Pharmacol. 426 (2001) 73-76
7. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., and Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292 (2001) 2499-2501
8. Carraway R., and Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248 (1973) 6854-6861
9. Cetin T., Freudenberg F., Fuchtemeier M., and Koch M. Dopamine in the orbitofrontal cortex regulates operant responding under a progressive ratio of reinforcement in rats. Neurosci. Lett. 370 (2004) 114-117
10. Chausmer A.L., and Ettenberg A. A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement. Pharmacol. Biochem. Behav. 57 (1997) 681-685
11. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
12. Ervin G.N., Birkemo L.S., Nemeroff C.B., and Prange A.J. Neurotensin blocks certain amphetamine-induced behaviours. Nature 291 (1981) 73-76
13. Ettenberg A., and Camp C.H. Haloperidol induces a partial reinforcement extinction effect in rats: implications for a dopamine involvement in food reward. Pharmacol. Biochem. Behav. 25 (1986) 813-821
14. Fauq A.H., Hong F., Cusack B., Tyler B.M., Pang Y.P., and Richelson E. Synthesis of (2S)-2-amino-3-(1H-4-indolyl) propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides. Tetrahedron: Asymmetry 9 (1998) 4127-4134
15. Fredrickson P., Boules M., Sally Y., and Richelson E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur. J. Pharmacol. 458 (2003) 111-118
16. Fredrickson P., Boules M., Sally Y., and Richelson E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res. 979 (2003) 245-248
17. Hanson G.R., and Keefe K.A. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Brain Res. Mol. Brain Res. 66 (1999) 111-121
18. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 9779-9783
19. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 17 (1997) 8580-8587
20. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., and Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 165 (1989) 337-338
21. Kalivas P.W., Volkow N., and Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45 (2005) 647-650
22. Kelley A.E., Baldo B.A., Pratt W.E., and Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav. 86 (2005) 773-795
23. Kiss A., Jezova D., and Aguilera G. Activity of the hypothalamic pituitary adrenal axis and sympathoadrenal system during food and water deprivation in the rat. Brain Res. 663 (1994) 84-92
24. Koch M., Schmid A., and Schnitzler H.U. Role of muscles accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology (Berlin) 152 (2000) 67-73
25. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8 (2005) 1442-1444
26. Lambert P.D., Gross R., Nemeroff C.B., and Kilts C.D. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system. Ann. N. Y. Acad. Sci. 757 (1995) 377-389
27. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25 (2001) 402-408
28. Marinelli M., and Piazza P.V. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 16 (2002) 387-394
29. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., and Koob G.F. Animal models of drug craving. Psychopharmacology (Berlin) 112 (1993) 163-182
30. McBride W.J., Murphy J.M., and Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 101 (1999) 129-152
31. Merchant K.M., Bush L.G., Gibb J.W., and Hanson G.R. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur. J. Pharmacol. 160 (1989) 409-412
32. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., and Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2088-2092
33. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., Le Moal M., and Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11738-11742
34. Rivet J.M., Stinus L., LeMoal M., and Mormede P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498 (1989) 149-153
35. Roberts D.C., Corcoran M.E., and Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6 (1977) 615-620
36. Roberts D.C., Koob G.F., Klonoff P., and Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12 (1980) 781-787
37. Robledo P., Maldonado R., and Koob G.F. Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622 (1993) 105-112
38. Rompre P.P. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. Peptides 16 (1995) 1417-1420
39. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 5 (2005) 34-41
40. Schmidt E.F., Sutton M.A., Schad C.A., Karanian D.A., Brodkin E.S., and Self D.W. Extinction training regulates tyrosine hydroxylase during withdrawal from cocaine self-administration. J. Neurosci. 21 (2001) RC137
41. Schultz W. Multiple reward signals in the brain. Nat. Rev., Neurosci. 1 (2000) 199-207
42. Self D.W. Neural substrates of drug craving and relapse in drug addiction. Ann. Med. 30 (1998) 379-389
43. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 (2004) 242-255
44. Self D.W., Barnhart W.J., Lehman D.A., and Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 27 (1996) 1586-1589
45. Self D.W., Choi K.H., Simmons D., Walker J.R., and Smagula C.S. Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn. Mem. 11 (2004) 648-657
46. Shaham Y., Erb S., and Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 33 (2000) 13-33
47. Sharf R., Lee D.Y., and Ranaldi R. Microinjections of SCH 23390 in the ventral tegmental area reduce operant responding under a progressive ratio schedule of food reinforcement in rats. Brain Res. 1033 (2005) 179-185
48. Studler J.M., Kitabgi P., Tramu G., Herve D., Glowinski J., and Tassin J.P. Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons. Neuropeptides 11 (1988) 95-100
49. Sutton M.A., and Beninger R.J. Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors. Psychopharmacology (Berlin) 144 (1999) 95-110
50. Taber M.T., and Fibiger H.C. Feeding-evoked dopamine release in the nucleus, accumbens: regulation by glutamatergic mechanisms. Neuroscience 76 (1997) 1105-1112
51. Tyler-McMahon B.M., Boules M., and Richelson E. Neurotensin: peptide for the next millennium. Regul. Pept. 93 (2000) 125-136
52. Wise R.A. Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits?. Life Sci. 22 (1978) 535-542
53. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 36 (2002) 229-240
54. Wise R.A. Dopamine and food reward: back to the elements. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 286 (2004) R13
55. Wise R.A., and Bozarth M.A. Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol. Biochem. Behav. 17 (1982) 239-243
56. Wolterink G., Phillips G., Cador M., Donselaar-Wolterink I., Robbins T.W., and Everitt B.J. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacology (Berlin) 110 (1993) 355-364